INCYIncyteHealth Care
$112.79EarningsOct 27, 2026
1D—1W—1M—3M—1Y—
Market cap$23.5BCompany infoRevenue$5.8B52-wk range$84 – $130IndustryBiotechnologyWebsiteincyte.comRelated
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +34.4% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E14.4×7890
13
472
P / S4.0×3243
3
6
P / FCF12.2×7385
12
770
EV / EBITDA9.3×7789
8
31
P / E (fwd)32.8×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin92.6%9896
92%
95%
Operating margin31.6%8689
-1%
32%
Net margin27.7%8892
0%
32%
ROE31.1%8287
1%
31%
ROIC23.7%8790
-1%
24%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009285
0.0
0.0
Net debt / EBITDA-2.2×9089
Current ratio4.669288
Interest coverage790.6×9290
Per shareTTM, with year-over-year change
Revenue / share$27.95▲ +27%
EPS (diluted)$7.85▲ +78%
FCF / share$9.22▲ +103%
Est. EPS growth (fwd)+146%